Original Study| Volume 21, ISSUE 6, P747-751.e1, June 2020

German Version of SARC-F: Translation, Adaption, and Validation

Published:January 21, 2020DOI:



      Translation, adaptation, and validation of the German version of the SARC-F for community-dwelling older adults in Germany.



      Setting and Participants

      117 community-dwelling outpatients with a mean age of 79.1 ± 5.2 years were included in the study; 94 (80.4%) of them were female. Sixty-three (53.8%) had a positive SARC-F score of ≥4 points. According to the definition of sarcopenia from the European Working Group on Sarcopenia in Older People (EWGSOP2), 8 patients (6.8%) were identified as sarcopenic and 57 (48.7%) as probable sarcopenic.


      According to EWGSOP2, probable sarcopenia was defined for patients with reduced hand grip strength (women: <16.0 kg; men: <27.0 kg) and/or impaired chair-rise time (both genders: >15 seconds). Patients with additional low skeletal muscle index were classified as sarcopenic (women: <5.5 kg/m2; men: <7.0 kg/m2). Translation and cultural adaption was composed of 7 different steps that were in general based on the guidelines put forward by the World Health Organization. Validation include test-retest and the inter-rater reliability (intraclass correlation coefficient) as well as internal consistency (Cronbach alpha). Furthermore, sensitivity, specificity, positive predictive value, and negative predictive value of the SARC-F were calculated. Receiver-operating characteristic analysis was performed to calculate the area under the curve.


      The translated and culturally adapted version of the SARC-F for the German language has shown excellent inter-rater reliability and good test-retest reliability. The internal consistency is acceptable. Sensitivity (63%) and specificity (47%) for sarcopenia is low. For detecting patients with probable sarcopenia, the SARC-F in the German version has shown 75% sensitivity and 67% specificity.

      Conclusions and Implications

      Because of a low sensitivity for detecting sarcopenia but an acceptable sensitivity for identifying probable sarcopenia, the German version of the SARC-F is a suitable tool for case finding of probable sarcopenia.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Beaudart C.
        • Zaaria M.
        • Pasleau F.
        • et al.
        Health outcomes of sarcopenia: A systematic review and meta-analysis.
        PLoS One. 2017; 12: e0169548
        • Phillips A.
        • Strobl R.
        • Vogt S.
        • et al.
        Sarcopenia is associated with disability status-results from the KORA-Age study.
        Osteoporos Int. 2017; 28: 2069-2079
        • De Spiegeleer A.
        • Beckwée D.
        • Bautmans I.
        • Petrovic M.
        Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG). Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: An umbrella review of systematic reviews and meta-analyses.
        Drugs Aging. 2018; 35: 719-734
        • Bauer J.
        • Biolo G.
        • Cederholm T.
        • et al.
        Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group.
        J Am Med Dir Assoc. 2013; 14: 542-559
        • Cruz-Jentoft A.J.
        • Baeyens J.P.
        • Bauer J.M.
        • et al.
        Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.
        Age Ageing. 2010; 39: 412-423
        • Cruz-Jentoft A.J.
        • Bahat G.
        • Bauer J.
        • et al.
        Sarcopenia: Revised European consensus on definition and diagnosis.
        Age Ageing. 2019; 48: 16-31
        • Malmstrom T.K.
        • Morley J.E.
        • SARC-F
        A simple questionnaire to rapidly diagnose sarcopenia.
        J Am Med Dir Assoc. 2013; 14: 531-532
        • Bahat G.
        • Yilmaz O.
        • Oren M.M.
        • et al.
        Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: Methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group.
        Eur Geriatr Med. 2018; 9: 23-28
        • World Health Organization
        Substance abuse: Research Tools; translation.
        (Available at:)
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • MacKenzie C.R.
        A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Rabin R.
        • de Charro F.
        EQ-SD: A measure of health status from the EuroQol Group.
        Ann Med. 2001; 33: 337-343
        • Kaiser M.J.
        • Bauer J.M.
        • Ramsch C.
        • et al.
        Validation of the Mini Nutritional Assessment short-form (MNA®-SF): A practical tool for identification of nutritional status.
        J Nutr Health Aging. 2009; 13: 782-788
        • Roberts H.C.
        • Denison H.J.
        • Martin H.J.
        • et al.
        A review of the measurement of grip strength in clinical and epidemiological studies: Towards a standardised approach.
        Age Ageing. 2011; 40: 423-429
        • Guralnik J.M.
        • Simonsick E.M.
        • Ferrucci L.
        • et al.
        A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission.
        J Gerontol. 1994; 49: M85-M94
        • Baumgartner R.
        • Koehler K.
        • Gallagher D.
        • et al.
        Epidemiology of sarcopenia among the elderly in New Mexico [erratum in Am J Epidemiol 1999;149:1161].
        Am J Epidemiol. 1998; 147: 755-763
        • Koo T.K.
        • Li M.Y.
        A guideline of selecting and reporting intraclass correlation coefficients for reliability research.
        J Chiropr Med. 2016; 15: 155-163
        • DeVellis R.F.
        Scale Development: Theory and Applications.
        2nd ed. Sage, London1991
        • Boehme P.
        • Hansen A.
        • Roubenoff R.
        • et al.
        How soon will digital endpoints become a cornerstone for future drug development?.
        Drug Discov Today. 2019; 24: 16-19
        • Hanley J.A.
        • McNeil B.J.
        A method of comparing the areas under receiver operating characteristic curves derived from the same cases.
        Radiology. 1983; 148: 839-843
        • Goodman M.J.
        • Ghate S.R.
        • Mavros P.
        • et al.
        Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004.
        J Cachexia Sarcopenia Muscle. 2013; 4: 187-197
        • Yu S.
        • Appleton S.
        • Chapman I.
        • et al.
        An anthropometric prediction equation for appendicular skeletal muscle mass in combination with a measure of muscle function to screen for sarcopenia in primary and aged care.
        J Am Med Dir Assoc. 2015; 16: 25-30
        • Ishii S.
        • Tanaka T.
        • Shibasaki K.
        • et al.
        Development of a simple screening test for sarcopenia in older adults.
        Geriatr Gerontol Int. 2014; 14: 93-101
        • Locquet M.
        • Beaudart C.
        • Reginster J.Y.
        • et al.
        Comparison of the performance of five screening methods for sarcopenia.
        Clin Epidemiol. 2017; 10: 71-82
        • Sánchez-Rodríguez D.
        • Marco E.
        • Dávalos-Yerovi V.
        • et al.
        Translation and validation of the Spanish version of the SARC-F questionnaire to assess sarcopenia in older people.
        J Nutr Health Aging. 2019; 23: 518-524
        • Beaudart C.
        • Locquet M.
        • Bornheim S.
        • et al.
        French translation and validation of the sarcopenia screening tool SARC-F.
        Eur Geriatr Med. 2018; 9: 29-37
        • Bahat G.
        • Yilmaz O.
        • Kiliç C.
        • et al.
        Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures.
        J Nutr Health Aging. 2018; 22: 898-903
        • Parra-Rodríguez L.
        • Szlejf C.
        • García-González A.I.
        • et al.
        Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults.
        J Am Med Dir Assoc. 2016; 17: 1142-1146
        • Ida S.
        • Murata K.
        • Nakadachi D.
        • et al.
        Development of a Japanese version of the SARC-F for diabetic patients: An examination of reliability and validity.
        Aging Clin Exp Res. 2017; 29: 935-942
        • Barbosa-Silva T.G.
        • Menezes A.M.B.
        • Bielemann R.M.
        • et al.
        Enhancing SARC-F: Improving Sarcopenia screening in the clinical practice.
        J Am Med Dir Assoc. 2016; 17: 1136-1141
        • Kim S.
        • Kim M.
        • Won C.W.
        Validation of the Korean version of the SARC-F Questionnaire to assess sarcopenia: Korean Frailty and Aging Cohort Study.
        J Am Med Dir Assoc. 2018; 19: 40-45.e1
        • Ida S.
        • Kaneko R.
        • Murata K.
        SARC-F for screening of sarcopenia among older adults: A meta-analysis of screening test accuracy.
        J Am Med Dir Assoc. 2018; 19: 685-689